C1-2015-06486. Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers  

  • Start Preamble

    Correction

    In notice document 2015-06486 appearing on pages 15226-15227 in the issue of Monday, March 23, 2015 make the following correction:

    On page 15226, in the third column, under the DATES heading, in the last line, “April 6, 2015” should read “April 7, 2015”.

    End Preamble

    [FR Doc. C1-2015-06486 Filed 3-31-15; 8:45 am]

    BILLING CODE 1505-01-P

Document Information

Published:
04/01/2015
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
C1-2015-06486
Pages:
17459-17459 (1 pages)
PDF File:
c1-2015-06486.pdf